Structure–Affinity and Structure–Kinetic Relationship Studies of Benzodiazepine Derivatives for the Development of Efficacious Vasopressin V2 Receptor Antagonists
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structure–Affinity and Structure–Kinetic Relationship Studies of Benzodiazepine Derivatives for the Development of Efficacious Vasopressin V2 Receptor Antagonists
Authors
Keywords
-
Journal
Journal of Medicinal Chemistry
Volume -, Issue -, Pages -
Publisher
American Chemical Society (ACS)
Online
2023-02-03
DOI
10.1021/acs.jmedchem.3c00015
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Benzodiazepine Derivatives as Potent Vasopressin V2 Receptor Antagonists for the Treatment of Autosomal Dominant Kidney Disease
- (2022) Xudong Cao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Long Residence Time at the Vasopressin V2 Receptor Translates into Superior Inhibitory Effects in Ex Vivo and In Vivo Models of Autosomal Dominant Polycystic Kidney Disease
- (2022) Haoran Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of mPGES ‐2 ameliorates NASH by activating NR1D1 via heme
- (2022) Dandan Zhong et al. HEPATOLOGY
- PF ‐06409577 inhibits renal cyst progression by concurrently inhibiting the mTOR pathway and CFTR channel activity
- (2022) Limin Su et al. FEBS Open Bio
- Revisit ligand-receptor interaction at the human vasopressin V2 receptor: A kinetic perspective
- (2020) Chunji Liu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A tolvaptan skeptic repents
- (2020) Brad H. Rovin KIDNEY INTERNATIONAL
- Autosomal dominant polycystic kidney disease: Disrupted pathways and potential therapeutic interventions
- (2019) Talieh Malekshahabi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Autosomal dominant polycystic kidney disease
- (2019) Emilie Cornec-Le Gall et al. LANCET
- Long residence time adenosine A1 receptor agonists produce sustained wash-resistant antilipolytic effect in rat adipocytes
- (2019) Yi Yun et al. BIOCHEMICAL PHARMACOLOGY
- Quercetin inhibits renal cyst growth in vitro and via parenteral injection in a polycystic kidney disease mouse model
- (2018) Yangyang Zhu et al. Food & Function
- OUP accepted manuscript
- (2018) NEPHROLOGY DIALYSIS TRANSPLANTATION
- The Role of Binding Kinetics in GPCR Drug Discovery
- (2015) David Swinney et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Translating slow-binding inhibition kinetics into cellular and in vivo effects
- (2015) Grant K Walkup et al. Nature Chemical Biology
- The drug–target residence time model: a 10-year retrospective
- (2015) Robert A. Copeland NATURE REVIEWS DRUG DISCOVERY
- Inhibition of Human Hepatic Bile Acid Transporters by Tolvaptan and Metabolites: Contributing Factors to Drug-Induced Liver Injury?
- (2015) Jason R. Slizgi et al. TOXICOLOGICAL SCIENCES
- Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action
- (2010) Georges Vauquelin et al. BRITISH JOURNAL OF PHARMACOLOGY
- Drug–target residence time: critical information for lead optimization
- (2010) Hao Lu et al. CURRENT OPINION IN CHEMICAL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now